1. Home
  2. NMRA vs BLDE Comparison

NMRA vs BLDE Comparison

Compare NMRA & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • BLDE
  • Stock Information
  • Founded
  • NMRA 2019
  • BLDE 2014
  • Country
  • NMRA United States
  • BLDE United States
  • Employees
  • NMRA N/A
  • BLDE N/A
  • Industry
  • NMRA
  • BLDE Aerospace
  • Sector
  • NMRA
  • BLDE Consumer Discretionary
  • Exchange
  • NMRA Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • NMRA 287.6M
  • BLDE 272.5M
  • IPO Year
  • NMRA 2023
  • BLDE N/A
  • Fundamental
  • Price
  • NMRA $1.13
  • BLDE $3.02
  • Analyst Decision
  • NMRA Buy
  • BLDE Strong Buy
  • Analyst Count
  • NMRA 8
  • BLDE 2
  • Target Price
  • NMRA $10.14
  • BLDE $6.25
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • BLDE 721.9K
  • Earning Date
  • NMRA 03-03-2025
  • BLDE 03-13-2025
  • Dividend Yield
  • NMRA N/A
  • BLDE N/A
  • EPS Growth
  • NMRA N/A
  • BLDE N/A
  • EPS
  • NMRA N/A
  • BLDE N/A
  • Revenue
  • NMRA N/A
  • BLDE $248,693,000.00
  • Revenue This Year
  • NMRA N/A
  • BLDE $5.29
  • Revenue Next Year
  • NMRA N/A
  • BLDE $8.99
  • P/E Ratio
  • NMRA N/A
  • BLDE N/A
  • Revenue Growth
  • NMRA N/A
  • BLDE 10.44
  • 52 Week Low
  • NMRA $1.13
  • BLDE $2.60
  • 52 Week High
  • NMRA $17.19
  • BLDE $5.17
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.07
  • BLDE 39.44
  • Support Level
  • NMRA $1.13
  • BLDE $2.81
  • Resistance Level
  • NMRA $1.23
  • BLDE $3.34
  • Average True Range (ATR)
  • NMRA 0.12
  • BLDE 0.21
  • MACD
  • NMRA 0.05
  • BLDE 0.02
  • Stochastic Oscillator
  • NMRA 3.54
  • BLDE 21.88

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: